[Antipsychotic drug therapy for patients with behavioral and psychological symptoms of dementia(BPSD)].
Kudo
Takashi
T
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology; D003704:Dementia / Q000188:drug therapy* / Q000209:etiology; D004298:Dopamine; D018491:Dopamine Agonists; D018492:Dopamine Antagonists; D006801:Humans; D011595:Psychomotor Agitation / Q000188:drug therapy* / Q000209:etiology; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000209:etiology; D011954:Receptors, Dopamine; D012306:Risk; D012701:Serotonin; D012702:Serotonin Antagonists
D014150:Antipsychotic Agents; D018491:Dopamine Agonists; D018492:Dopamine Antagonists; D011954:Receptors, Dopamine; D012702:Serotonin Antagonists; D012701:Serotonin; D004298:Dopamine